Skip to main content

Cranial Stabilization Devices Market to Witness Upward Trend with Approval of Spinal Stabilization System

 


The cranial stabilization devices market is expected to witness significant growth in the foreseeable future due to various factors such as high incidence of neurological disorders, increasing geriatric population, and high number of emergency surgeries.

Impact of Neurological Disorders on Cranial Stabilization Devices Market Growth

Neurological disorders include, acute spinal cord injury, Alzheimer's disease, brain tumors, cerebral aneurysm, epilepsy, and others. Cranial stabilization devices are designed for patient positioning in the prone, supine, and sitting positions during surgeries involving the brain and neck. According to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Such trend suggests high demand for cranial stabilization devices in North America.

The U.S is also witnessing high incidence of brain tumor. According to The Central Brain Tumor Registry of the United States (2020 CBTRUS Statistical Report), the incidence rate of all primary malignant and non-malignant brain and other central nervous system tumors in the U.S was 23.79 cases per 100,000 for a total count of 415,411 incident tumors. Such trend suggests high demand for cranial stabilization devices in the U.S.

Relation between Growing Geriatric Population and Growth of Cranial Stabilization Devices Market

Geriatric population is prone to various orthopedic and neurological diseases that involve use of cranial stabilization devices. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. This also suggests significant demand for cranial stabilization devices in Asia Pacific.        

Geriatric population, as earlier mentioned, is vulnerable to orthopedic diseases. Treatment of such diseases may require the use of cranial stabilization devices. According to researchers at the National Spinal Cord Injury Statistical Center at University of Alabama at Birmingham, as of 2019, 17,730 new spinal cord injury cases occur annually and between 249,000 and 363,000 people are currently living with spinal cord injuries in the U.S.

New Developments in Cranial Stabilization Devices Market

In November 2020, the U.S. Food and Drug Administration gave 510(k) clearance to SeaSpine Holdings Corporation's Mariner Cap System that is used to offer temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. SeaSpine Holdings Corporation is a U.S.-based manufacturer of surgical solutions for the treatment of patients suffering from spinal disorders.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Custom Antibody Service Market Segmentation Application, Technology and Market Analysis to 2028

  The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal  antibodies  are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. Global custom antibody service market is estimated to be valued at  US$ 444.85 Million in 2022  and expected to reach  US$ 930.46 million by 2030 , witnessing a  CAGR of 9.7 %  over...
Post a Comment
Read more